US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

165.73

+2.351.44%

Pre-market: 165.740.0100+0.01%06:01 EDT

Volume:10.02M

Turnover:1.66B

Market Cap:11.52B

PE:9.09

High:167.91

Open:164.60

Low:163.74

Close:163.38

52wk High:169.68

52wk Low:88.60

Shares:69.53M

Float Shares:69.53M

Volume Ratio:1.04

T/O Rate:14.41%

Dividend:0.56

Dividend Rate:0.34%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Fortress Biotech Q2 EPS $(0.08) Beats $(0.20) Estimate, Sales $18.718M Beat $18.300M Estimate

Benzinga Earnings

Press Release: Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results

Press Release: Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech

Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Idexx Laboratories (IDXX)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS)

Analysts Conflicted on These Healthcare Names: Fate Therapeutics (FATE) and Mediwound (MDWD)

Health Care Roundup: Market Talk

Insulet (PODD) Receives a Hold from Citi

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)

Citi Remains a Buy on Vor Biopharma (VOR)

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)

Citi Remains a Buy on Acumen Pharmaceuticals (ABOS)

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)

Alto Neuroscience, Inc. (ANRO) Receives a Buy from Jefferies

Aveanna Healthcare up over 17%, on Track for Highest Close Since July 2021

Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB) and Biomea Fusion (BMEA)

Analysts Have Conflicting Sentiments on These Healthcare Companies: ProKidney (PROK), Eton Pharmaceuticals (ETON) and Dyadic International (DYAI)

Sector Update: Healthcare Stocks Advance Pre-Bell Thursday

MT Newswires Live

Analysts’ Top Healthcare Picks: OrthoPediatrics (KIDS), Perrigo Company (PRGO)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/XBI/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":165.73,"timestamp":1787342400000,"preClose":163.38,"halted":0,"volume":10016422,"hourTrading":{"tag":"盘前","latestPrice":165.74,"preClose":165.73,"latestTime":"06:01 EDT","volume":819,"amount":135938.10321,"timestamp":1787565701382,"change":0.01,"changeRate":0.00006,"amplitude":0.004277},"delay":0,"changeRate":0.014383645489043912,"floatShares":69525000,"shares":69525000,"eps":18.23,"marketStatus":"Pre-Mkt","change":2.35,"latestTime":"08-24 06:12:40 EDT","open":164.6,"high":167.9112,"low":163.74,"amount":1663136725.302,"amplitude":0.025531,"askPrice":166.27,"askSize":200,"bidPrice":165.74,"bidSize":101,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":165.73,"sharesOutstanding":63325000,"nav":165.682052,"aum":11336794406.12,"dividendRate":0.0034,"bidAskSpread":0.000298,"preHourTrading":{"tag":"盘前","latestPrice":165.74,"preClose":165.73,"latestTime":"06:01 EDT","volume":819,"amount":135938.10321,"timestamp":1787565701382,"change":0.01,"changeRate":0.00006,"amplitude":0.004277},"postHourTrading":{"tag":"盘后","latestPrice":166.35,"preClose":165.73,"latestTime":"19:59 EDT","volume":85473,"amount":14172263.124,"timestamp":1787356794970,"change":0.62,"changeRate":0.003741,"amplitude":0.005008},"volumeRatio":1.0362914545448074,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1789704000000,"strike":"157.0","timestamp":1787329639281,"price":2.21,"volume":1350,"amount":298350,"type":"-"},{"symbol":"XBI","call":false,"expireDate":1789704000000,"strike":"150.0","timestamp":1787329639281,"price":0.99,"volume":1350,"amount":133650,"type":"+"}]},"impliedVol":0.3255,"impliedVolPercentile":0.732},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":69525000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0362914545448074,"shares":69525000,"dividePrice":0.5635,"high":167.9112,"amplitude":0.025531,"preClose":163.38,"low":163.74,"week52Low":88.6,"pbRate":"--","week52High":169.68,"institutionHeld":0.8511,"latestPrice":165.73,"committee":-0.328904,"eps":18.23,"divideRate":0.0034,"volume":10016422,"delay":0,"ttmEps":18.23,"open":164.6,"prevYearClose":121.93,"prevWeekClose":165.73,"prevMonthClose":147.01,"prevQuarterClose":158.25,"fiveDayClose":157.41,"twentyDayClose":150.48,"sixtyDayClose":134.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659816711","title":"Fortress Biotech Q2 EPS $(0.08) Beats $(0.20) Estimate, Sales $18.718M Beat $18.300M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659816711","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659816711?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:28","pubTimestamp":1786652936,"startTime":"0","endTime":"0","summary":"Fortress Biotech Q2 EPS $(0.08) Beats $(0.20) Estimate, Sales $18.718M Beat $18.300M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/FBIO","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","FBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167597","title":"Press Release: Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167597","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167597?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652100,"startTime":"0","endTime":"0","summary":"million for the three months ended June 30, 2026 compared to $0.9 million. for the same period last year primarily due to increased expenses for. manufacturing-related activities and other preparations for the planned. Phase 2 clinical study of EB06 in vitiligo patients, as well as increased. unallocated research costs, which were partially offset by decreased","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","ARDS","BK4588","XBI","BK4581","EDSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659216257","title":"Press Release: Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659216257","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659216257?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:05","pubTimestamp":1786651500,"startTime":"0","endTime":"0","summary":"Total net revenue increased 14% to $18.7 million for second quarter of 2026 compared to second quarter of 2025Partnered programs continue to advance with Crystalys Therapeutics announcing its $130 mil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","DERM","BK4232","BK4604","BK4555","BK4139","BK4581","HELS","BK4585","BK4099","XBI","FBIO","TM","BK4007","BK4588","R","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659164587","title":"The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2659164587","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659164587?lang=en_us&edition=fundamental","pubTime":"2026-08-14 02:31","pubTimestamp":1786645860,"startTime":"0","endTime":"0","summary":"Stunning Brain-Cancer Data Are Putting NeOnc’s Nose-to-Brain Delivery Platform, and Its Broader Potential, Front and CenterDENVER, Aug.  13, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings’ (NASD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/13/3344837/0/en/the-nose-knows-why-neonc-s-patent-portfolio-could-make-nthi-more-than-a-one-drug-biotech.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTHI","BK4581","XBI","BK4585","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659668161","title":"Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Idexx Laboratories (IDXX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659668161","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659668161?lang=en_us&edition=fundamental","pubTime":"2026-08-14 02:00","pubTimestamp":1786644021,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Achieve Life Sciences (ACHV) and Idexx Laboratories ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-achieve-life-sciences-achv-and-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-achieve-life-sciences-achv-and-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GB00B4QBRK32.GBP","IDXX","LABU","BK4504","LU0690374961.EUR","XLV","BK4567","LU0170899867.USD","LU0029874061.USD","LU2404859667.USD","HCSG","ACHV","LU0128526141.USD","GB00B4LPDJ14.GBP","LU2404859741.USD","LU0345774631.USD","BK4581","LU1941712264.USD","LU1291159041.SGD","LU1941712348.USD","BK4082","BK4585","BK4588","XBI","LU1989771016.USD","LU0690374615.EUR","BK4139","BK4137","PAWZ","LU0345774391.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659691971","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659691971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659691971?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:20","pubTimestamp":1786641612,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-candel-therapeutics-cadl-lensar-lnsr-and-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-candel-therapeutics-cadl-lensar-lnsr-and-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LABU","LNSR","XLV","BK4581","BK4082","LU0029874061.USD","BK4585","BK4588","XBI","BK4139","BK4137","HCSG","CADL","LU0128526141.USD","PYXS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659169563","title":"Analysts Conflicted on These Healthcare Names: Fate Therapeutics (FATE) and Mediwound (MDWD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169563","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659169563?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:50","pubTimestamp":1786639807,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fate Therapeutics (FATE) and Mediwound (MDWD). Fat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-fate-therapeutics-fate-and-mediwound-mdwd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-fate-therapeutics-fate-and-mediwound-mdwd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD","BK4581","XBI","BK4137","BK4588","BK4139","LU0029874061.USD","HCSG","BK4585","LABU","FATE","LU0128526141.USD","XLV","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659461166","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2659461166","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659461166?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:20","pubTimestamp":1786638000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1158 ET - Drugmakers are delaying or forgoing the launch of new ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4588","XBI","BK4581","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166442","title":"Insulet (PODD) Receives a Hold from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166442","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166442?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:15","pubTimestamp":1786637746,"startTime":"0","endTime":"0","summary":"Citi analyst Joanne Wuensch maintained a Hold rating on Insulet today and set a price target of $150.00. Wuensch covers the Healthcare sector, focu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/insulet-podd-receives-a-hold-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/insulet-podd-receives-a-hold-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","LABU","BK4585","XLV","BK4581","LU2065171402.SGD","XBI","LU1084165304.USD","LU2065170008.USD","LU2324357040.USD","LU1261432733.SGD","LU2065169927.USD","BK4566","BK4082","LU1119994496.HKD","LU2065171311.SGD","LU0728928796.USD","PODD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166348","title":"Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166348?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:00","pubTimestamp":1786636814,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apogee Therapeutics (APGE) and Biogen (BIIB). Apog...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IE00B19Z9P08.USD","LU0320765992.SGD","XLV","IE00B894F039.SGD","LU0109394709.USD","LU0029874061.USD","LU0234570918.USD","BK4532","BK4139","BMED","IE00B19Z9Z06.USD","PBE","LU0128526141.USD","APGE","XBI","LU0053671581.USD","HCSG","BIIB","SBIO","LABU","BK4581","BK4588","BK4533","LU0889565916.HKD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659816653","title":"Citi Remains a Buy on Vor Biopharma (VOR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659816653","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659816653?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:55","pubTimestamp":1786636543,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham maintained a Buy rating on Vor Biopharma today and set a price target of $50.00. Meacham covers the Healthcare sector, f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-vor-biopharma-vor-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-vor-biopharma-vor-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4588","LABU","BK4585","XBI","VOR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659663051","title":"Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659663051","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659663051?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:50","pubTimestamp":1786636209,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Liquidia Technologies (LQDA), AbbVie (ABBV) and Esta...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-liquidia-technologies-lqda-abbvie-abbv-and-establishment-labs-holdings-esta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-liquidia-technologies-lqda-abbvie-abbv-and-establishment-labs-holdings-esta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LABU","LU2237443978.SGD","SG9999015978.USD","LU0949170772.SGD","IE00B4R5TH58.HKD","XBI","IE000F7OJYX1.SGD","LU0795875169.SGD","LU1989772840.SGD","LU0198837287.USD","IE0002141913.USD","PPH","RXL","IE0009355771.USD","IE00BN8TJ469.HKD","PJP","IE0004445239.USD","LU0738911758.USD","LU2125909247.SGD","BK4559","LU2089283258.USD","BK4585","ESTA","LQDA","LU0256863811.USD","LU0965508806.USD","LU1934455194.USD","IE00BLSP4239.USD","LU0058720904.USD","IYH","LU0965509010.AUD","GLAM","VHT","XLV","IXJ","LU0965509283.SGD","LU0124676726.USD","FTXH","LU0942090050.USD","FHLC","AGNG","IE00BVYPNW00.USD","TRUH","SG9999011175.SGD","LU0545039389.USD","LU1267930573.SGD","JDOC","ABBV","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659663411","title":"Citi Remains a Buy on Acumen Pharmaceuticals (ABOS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659663411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659663411?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:46","pubTimestamp":1786635988,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham maintained a Buy rating on Acumen Pharmaceuticals today and set a price target of $4.00. Meacham covers the Healthcare s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-acumen-pharmaceuticals-abos-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-acumen-pharmaceuticals-abos-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4581","XLV","BK4139","BK4588","ABOS","XBI","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165757","title":"Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165757","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165757?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:40","pubTimestamp":1786635611,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-spyre-therapeutics-syre-and-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-spyre-therapeutics-syre-and-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMDX","LFSC","LU2065731478.USD","LABU","CMPS","BK4581","BK4082","HCSG","BK4585","BK4139","BK4137","LU2324357040.USD","PSIL","LU0029874061.USD","BK4588","XLV","XBI","SYRE","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165831","title":"Alto Neuroscience, Inc. (ANRO) Receives a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165831","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165831?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:45","pubTimestamp":1786632344,"startTime":"0","endTime":"0","summary":"Jefferies analyst Andrew Tsai maintained a Buy rating on Alto Neuroscience, Inc. today and set a price target of $40.00. Tsai covers the Healthcare...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alto-neuroscience-inc-anro-receives-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alto-neuroscience-inc-anro-receives-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4585","XLV","BK4588","ANRO","BK4007","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659638163","title":"Aveanna Healthcare up over 17%, on Track for Highest Close Since July 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2659638163","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659638163?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:41","pubTimestamp":1786632060,"startTime":"0","endTime":"0","summary":"Aveanna Healthcare Holdings Inc  is currently at $10.64, up $1.59 or 17.51%--Would be highest close since July 23, 2021, when it closed at $10.84--On pace for largest percent increase since Aug. 7, 2025, when it rose 49.36%--Currently up two consecutive days; up 18.83% over this period--Best two day stretch since the two days ending Aug. 8, 2025, when it rose 57.84%--Up 13.26% month-to-date--Up 30.17% year-to-date--Down 17.49% from its all-time closing high of $12.89 on June 14, 2021--Up 47.71% from 52 weeks ago , when it closed at $7.20--Would be a new 52-week closing high--Up 70.98% from its 52-week closing low of $6.22 on April 10, 2026--Traded as high as $10.80; highest intraday level since July 26, 2021, when it hit $10.99--Up 19.34% at today's intraday high; largest intraday percent increase since Aug. 7, 2025, when it rose as much as 59.38%All data as of 10:38:37 AM ETSource: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","BK4588","XLV","BK4196","AVAH","LABU","LU0128526141.USD","XBI","BK4581","BK4137","HCSG","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659168244","title":"Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB) and Biomea Fusion (BMEA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659168244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659168244?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:10","pubTimestamp":1786630208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Connect Biopharma Holdings (CNTB) and Biomea Fusion ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-connect-biopharma-holdings-cntb-and-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-connect-biopharma-holdings-cntb-and-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","CNTB","BK4539","BK4581","XBI","LABU","BK4585","LU0029874061.USD","BK4139","BK4588","XLV","BMEA","HCSG","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659150152","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: ProKidney (PROK), Eton Pharmaceuticals (ETON) and Dyadic International (DYAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659150152","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659150152?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:40","pubTimestamp":1786628423,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ProKidney (PROK), Eton Pharmaceuticals (ETON) and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-prokidney-prok-eton-pharmaceuticals-eton-and-dyadic-international-dyai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-prokidney-prok-eton-pharmaceuticals-eton-and-dyadic-international-dyai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ETON","BK4588","LU0029874061.USD","XLV","PROK","BK4139","LABU","LU0128526141.USD","XBI","BK4581","BK4137","BK4007","HCSG","DYAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659574871","title":"Sector Update: Healthcare Stocks Advance Pre-Bell Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2659574871","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659574871?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:13","pubTimestamp":1786626787,"startTime":"0","endTime":"0","summary":"Healthcare stocks were advancing pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF  up 0.3% and the iShares Biotechnology ETF  0.6% higher.MeiraGTx  shares were up more than 7% after the company reported that it swung to a Q2 net income as revenue surged during the period.Cullinan Therapeutics , Taiho Oncology and Taiho Pharmaceutical said a phase 3 clinical trial evaluating the combination of their jointly developed drug zipalertinib and chemotherapy as a first-line treatment for adults with previously untreated, locally advanced or metastatic non-small cell lung cancer met its primary endpoint of progression-free survival. Shares of Cullinan Therapeutics were up more than 7% premarket.Ascendis Pharma  stock was up more than 1% after the company posted higher Q2 non-IFRS earnings and revenue.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","HCSG","BK4585","BK4139","LABU","LU0128526141.USD","MEDI","XLV","BK4588","LU0320765992.SGD","LU0889565916.HKD","CGEM","LU0109394709.USD","BK4581","IBB","XBI","MGTX","LU0029874061.USD","ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659152671","title":"Analysts’ Top Healthcare Picks: OrthoPediatrics (KIDS), Perrigo Company (PRGO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659152671","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659152671?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:40","pubTimestamp":1786624813,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on OrthoPediatrics (KIDS), Perrigo Company (PRGO) and M...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-orthopediatrics-kids-perrigo-company-prgo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-orthopediatrics-kids-perrigo-company-prgo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LABU","LU0029874061.USD","BK4198","LU0128526141.USD","XLV","BK4585","XBI","IE00BFMHRM44.USD","BK4007","KIDS","PRGO","BK4581","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":13,"totalSize":384,"code":"91000000","status":"200"}]}}